GL1X · GenesisL1 explorer

Research workbench

Crystal structure of dimeric RXR-LBD complexed with NEt-3ME and TIF2 co-activator

Analyse Crystal structure of dimeric RXR-LBD complexed with NEt-3ME and TIF2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6LB4
Type
protein
Length
228 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.5
Source
Homo sapiens; SYNTHETIC CONSTRUCT
Molecule
Retinoic acid receptor RXR-alpha; Nuclear receptor coactivator 2
UniProt
P19793, Q15596
Ligands
E8L
Pockets
2 · best druggability 0.84

Structure

x-ray diffraction · resolution 1.5 · 2 distinct chains · 70% helix, 4% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ARetinoic acid receptor RXR-alphaprotein21870% helix, 4% strandP19793
BNuclear receptor coactivator 2protein1070% helix, 0% strandQ15596

Ligands and binding sites

  • E8L · 6-[ethyl-[3-(2-methoxyethoxy)-4-propan-2-yl-phenyl]amino]pyridine-3-carboxylic acid · ligand · chains A
  • EDO · 1,2-ethanediol · additive · 4 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12120.840.9629E8L
21030.370.7521empty

Interfaces

1 interface between chains.

  • A–B · 570 Ų buried · 6 hydrogen bonds · protein-protein

Compared structures

  • 6LB4 · Crystal structure of dimeric rxr-lbd complexed with net-3ME and TIF2 co-activator · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.